About
Generative AI for Peptide Drug Design
Areas of Focus
Categories
AI Focused
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
735
By Phase
PHASE2/PHASE3: 1
By Status
ACTIVE_NOT_RECRUITING: 2COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06561230Collaborator
Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
N/AActive, not recruiting
300 participants
Started: Apr 4, 2025 · Completed: Apr 30, 2026
NCT06561217Collaborator
Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening
N/ACompleted
355 participants
Started: Aug 18, 2023 · Completed: Jul 12, 2024
NCT05520476Lead Sponsor
Neuroliten MVP System Clinical Observation Study
N/AActive, not recruiting
20 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2024
NCT04737967Lead Sponsor
The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy
PHASE2/PHASE3Unknown
60 participants
Started: Feb 15, 2021 · Completed: Oct 1, 2021
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...